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We previously reported that tumor mitochondrial redox state and its heterogeneity distinguished between the
aggressive and the indolent breast cancer xenografts, suggesting novel metabolic indices as biomarkers for
predicting tumor metastatic potential. Additionally, we reported that the identified redox biomarkers successfully
differentiated between the normal breast tissue and the cancerous breast tissue from breast cancer patients. The
aim of the present study was to further characterize intratumor heterogeneity by its distribution of mitochondrial
redox state and glucose uptake pattern in tumor xenografts and to further investigate the metabolic heterogeneity
of the clinical biopsy samples. We employed the Chance redox scanner, a multi-section cryogenic fluorescence
imager to simultaneously image the intratumor heterogeneity in the mitochondrial redox state and glucose uptake
at a high spatial resolution (down to 50 × 50 × 20 μm3). The mitochondrial redox state was determined by the ratio
of the intrinsic fluorescence signals from reduced nicotinamide adenine dinucleotide (NADH) and oxidized
flavoproteins (Fp including FAD, i.e., flavin adenine dinucleotide), and the glucose uptake was measured using a
near-infrared fluorescent glucose-analogue, pyropheophorbide 2-deoxyglucosamide (Pyro-2DG). Significant inter-
and intratumor metabolic heterogeneity were observed from our imaging data on various types of breast cancer
xenografts. The patterns and degrees of heterogeneity of mitochondrial redox state appeared to relate to tumor
size and metastatic potential. The glucose uptake was also heterogeneous and generally higher in tumor
peripheries. The oxidized and reduced regions mostly corresponded with the lower and the higher pyro-2DG
uptake, respectively. However, there were some regions where the glucose uptake did not correlate with the redox
indices. Pronounced glucose uptake and high NADH were observed in certain localized areas within the tumor
necrotic regions, indicative of the existence of viable cells which was also supported by the H&E staining.
Significant heterogeneity of the redox state indices was also observed in clinical specimens of breast cancer
patients. As abnormal metabolism including the Warburg effect (high glycolysis) plays important roles in cancer
transformation and progression, our observations that reveal the 3D intratumor metabolic heterogeneity as a
characteristic feature of breast tumors are of great importance for understanding cancer biology and developing
diagnostic and therapeutic methods.
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Abnormal metabolism and high variability in disease pre-
sentations are among the hallmarks of cancer (Heppner &
Miller 1998; Hanahan & Weinberg 2011). The intratumor
heterogeneity or diversity has been associated with tumor
progression and aggressiveness (Heppner 1984; Allred et al.
2008; Park et al. 2010). It is therefore of great importance
to characterize tumor metabolic heterogeneity.
Cancer metabolism has been an active research area for
understanding tumor biology and developing biomarkers
for cancer diagnosis and monitoring treatment response
(Cairns et al. 2011; Vander Heiden et al. 2009). Higher
than normal glucose uptake/metabolism as first identified
by Otto Warburg in 1920s (Koppenol et al. 2011), lays the
foundation for cancer staging by fluorinated 2-deoxyglucose
positron emission tomography (FDG-PET) in the clinic.
Studies also investigated the glucose uptake and its spatial
heterogeneity in animal models (Kallinowski et al. 1988;
Dearling et al. 2004). Another area under active research
investigation is mitochondrial metabolism including TCA
cycle and oxidative phosphorylation. Several mitochon-
drial metabolic enzymes have been identified as oncogenes
or tumor suppressors in some cancers (Thompson 2009).
Previously we reported that the mitochondrial redox
state and its heterogeneity in tumors imaged by the
Chance redox scanner provide sensitive and potentially
diagnosis-useful indices for differentiating among five
human melanoma lines and two breast cancer lines with
different metastatic potential in mouse models (Li et al.
2009a; Xu et al. 2010) . In addition, we reported that the
redox imaging indices differentiated between the normal
and cancerous breast tissues from breast cancer patients
(Xu et al. 2013a). We showed that the aggressive or meta-
static tumors have localized more oxidized areas (higher
Fp redox ratio, Fp/(Fp +NADH)), and that the Fp redox
ratios of the oxidized areas positively correlated with
tumor metastatic potential and thus could be further de-
veloped for grading tumor aggressiveness of human mela-
noma and breast cancer. The pattern of the oxidized areas
with surrounding reduced areas appears to be a distinct
feature of intratumor heterogeneity in aggressive tumors.
However, the 3D heterogeneity of the mitochondrial redox
indices (NADH, Fp, and the Fp redox ratio) has not been
thoroughly investigated for whole tumors.
Because of cancer cells’ higher than normal glycolysis,
simultaneously imaging the glucose uptake/metabolism
and the mitochondrial redox state in tumors adds one
more dimension to our understanding of tumor metabo-
lism. As the size of an oxidized tumor area can be as small
as 1–2 mm (Xu et al. 2010), FDG-PET is not suitable for
such a purpose due to its low spatial resolution (1–2 mm
for small animals and ~4 mm for human subjects). Previ-
ously, Zheng and co-workers developed the near-infrared
fluorescent glucose-analog Pyro-2DG and also confirmedthat Pyro-2DG was selectively accumulated in tumor cells
via the glucose transporters (Zhang et al. 2003). Using the
high-resolution Chance redox scanner, they achieved
simultaneous imaging of Pyro-2DG uptake and the redox
indices of the 9L glioma and c-MYC-induced mammary
tumors in animal models (Zhang et al. 2004). The imaging
data showed that Pyro-2DG uptake correlated well with
the reduced redox state and did not affect the redox state
of the tumor tissue.
In the present study, we first report the 3D distributions
of the mitochondrial redox state in the three breast tumor
xenografts in nude mice. We also report the significant
intra-tumor heterogeneity of the mitochondrial redox
state observed in tumor samples from breast cancer
patients. We then show the glucose uptake distribution
pattern and its correlations with the redox indices in the
breast tumor xenografts. A portion of the preliminary data
from mouse models were published in a conference
proceeding (Xu et al. 2012; Xu et al. 2011a). The results
are useful for deepening our understanding on tumor
metabolism and its heterogeneity, which may drive the
development of novel diagnostic and therapeutic methods
for cancer management.Materials and methods
Tumor models and sample preparation for redox
scanning
The animal protocols were approved by the Institutional
Animal Care and Use Committee at the University of
Pennsylvania. Subcutaneous xenografts of three human
breast cancer cell lines with increasing metastatic potential
(MCF-7 <MDA-MB-468 <MDA-MB-231, N ≥ 5 for each
line) were grown to 6–10 mm in diameter in athymic
nude mice for the 3D redox scanning. Another two MDA-
MB-231 tumor xenografts (>10 mm in diameter and with
an apparent necrotic center, average tumor volume =
989 mm3) and two MCF-7 tumor xenografts (>10 mm in
diameter, average tumor volume = 750 mm3) were used
for simultaneous imaging of Pyro-2DG uptake and the re-
dox state. Pyro-2DG was administered to the anesthetized
mice through tail vein injection at a dosage of ~2.5 mg/kg
after the tumor-bearing mice were starved for 24 hrs. In
approximately two hours, the anesthetized mice were
snap-frozen using liquid nitrogen. The snap-freezing
protocol maintained the in vivo mitochondrial redox state
for the ex vivo redox scanning. The preparation of tissue
samples for the redox scanning were previously described
(Xu et al. 2010; Xu et al. 2009a). Briefly, the excised frozen
samples were embedded with chilled mounting buffer
(ethanol:glycerol:water = 10:30:60). Frozen reference stan-
dards of NADH, FAD, and Pyro-2DG with known concen-
trations (in 10 mM Tris–HCl buffer, pH ~7) were quickly
mounted adjacent to the tissue for the purpose of
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cules in tissue.
Human breast tumor tissue collection
Tissue collection from patients was performed according
to a protocol approved by the Internal Review Board of
the University of Pennsylvania. Both normal and cancer-
ous tissue specimens were collected from the cancer-
bearing breasts of three patients shortly after surgical
resection. Core biopsies and/or thin tissue blocks were
obtained from tumor and normal adjacent breast tissue,
respectively and were snap-frozen in liquid nitrogen
within 5–15 minutes after the tissue removal from the
body. These tissue specimens were embedded in the same
way as described for the xenografts aforementioned.
Redox scanning using the chance redox scanner
The low-temperature redox scanner developed by Chance
et. al (Chance et al. 1979; Gu et al. 2002; Li et al. 2009b;
Quistorff et al. 1985) (the Chance redox scanner) was
employed to obtain the multi-slice fluorescence images of
NADH, Fp, and Pyro-2DG. The optical filters were
430 nm ± 25 nm and 525 nm ± 32 nm for Fp excitation
and emission channel respectively; 360 nm ± 13 nm and
430 nm ± 25 nm for NADH excitation and emission chan-
nel, respectively; and 430 ± 28 nm and 670± 11 nm for
pyro-2DG excitation and emission, respectively. For the
3D imaging study, the tumor samples were scanned
section by section at different tissue depths with 400 ~
800 μm spacing. Most tumors were scanned at least to the
center. For some tumors the entire tumor was scanned.
For the study of simultaneous imaging of NADH, Fp, and


























































































































Figure 1 Typical images of redox scanning of the mouse xenografts o
d = 1200 μm), and MDA-MB-231 (right, d = 800 μm) tumor lines. The
images are in the unit of μM in reference to the corresponding standards.
ratio or concentration. The y axes represent the number of pixels in the tu
concentration. The small round spots outside the tumor section are the im
numbers on the bottom and left axes to indicate the positions of the imag3 tissue sections with depth ranging from ~1700-3000 μm
under the mouse skin.
Data analysis
The nominal concentration of NADH, Fp, and pyro-2DG
in tissue was interpreted using the fluorescence intensity
of the corresponding reference standard, respectively and
further used to calculate Fp/(NADH+ Fp) or NADH/
(Fp +NADH). To account for the cell or mitochondria
density difference at different regions within a tumor, the
normalized Pyro-2DG, i.e. Pyro-2DG/(NADH+ Fp) was
also calculated based on the nominal concentrations of
NADH and Fp.
In order to obtain the mean values in the more oxidized
regions (high Fp redox ratio or Fp/(NADH+ Fp)) and less
oxidized regions (low Fp redox ratio), the sum of two







fitted to the histograms of the NADH, Fp, and Fp redox
ratio images (Xu et al. 2013b). The fitted bi (i = 1, 2) values
were taken as the means of these redox indices in the
corresponding more or less oxidized region.
Results
3D redox images show high degree intertumor and
intratumor heterogeneity
We have observed significant inter- and intratumor het-
erogeneity in the mitochondrial redox state in the breast
cancer mouse xenografts. As the representative tumors
shown in Figure 1, both aggressive lines (MDA-MB-231
and MDA-MB-468) displayed high degree of heterogene-
ity of NADH, Fp and the Fp redox ratio in each section,














































































f MCF-7 (left, depth d = 3400 μm), MDA-MB-468 (middle
Fp or NADH redox ratio ranges between 0 and 1; the Fp or NADH
The x axes of the corresponding histograms represent the Fp redox
mor section having a specific value of Fp redox ratio or Fp and NADH
ages of Fp or NADH reference standards. The images are labeled with
e matrices with a spatial resolution of 200 μm.
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gions (usually tumor peripheries). A bimodal distribution
is observed in their histograms. The indolent MCF-7 tu-
mors (≤10 mm) were relatively less heterogeneous in each
section, with a lower Fp redox ratio on average than that
of the oxidized regions of the aggressive tumors. However,
as we will show below, the MCF-7 tumors with larger size
also showed high degree of heterogeneity with a clear
center-periphery pattern.
To see how the redox indices change along the depth of
each tissue section, they were plotted against the depth of
each tumor section of the three tumors in Figure 1 to
demonstrate how the redox indices distribute globally
within a tumor (Figure 2). The left column of Figure 2
contains the plots of section average value of each of the
redox indices versus depth. It is clearly seen that all three
redox indices vary with depth for each tumor line. The ag-
gressive tumors appear to have higher variations than the
less aggressive MCF-7, demonstrating their higher degree
of heterogeneity along section depth in addition to that
exhibited on each section. We can see that the most
aggressive tumor MDA-MB-231 has the highest Fp and
the Fp redox ratio values, indicating it is the most oxidized
tumor.
In addition to the section average values, for the aggres-
sive tumors, we also obtained the mean values of the













































































































































































Figure 2 Depth-dependence of redox indices (1st row: Fp; 2nd row: NA
tumor sections for three lines; Middle and right column: the mean values i
tumor, respectively.regions) and those of the rim (defined as low Fp redox
ratio regions) by fitting of two Gaussian functions to their
corresponding histograms. The plots in the middle col-
umn of Figure 2 are for the MDA-MB-468 tumor. We can
see that the core and the rim are clearly separated for all
three redox indices in the entire range of tissue depth. Fp
is higher in the core area but drops sharply at 2200 μm
and similar pattern is seen for Fp in the rim area. NADH
distributions are roughly opposite to those of Fp with the
maxima at 1900 μm. The Fp redox ratio is markedly
higher in the core than in the rim. In comparison, the
redox indices of the core and rim of the MDA-MB-231
tumor exhibited a different depth-variation pattern, but
had a similar separation between the rim and core except
at one depth point for NADH (Figure 2, right column).
All these patterns of the aggressive tumors can be charac-
terized by a bimodal distribution of the mitochondrial
redox state with a more and a less oxidized region.
Figure 3 displays the typical redox images of a breast
cancer tissue block from a patient, who had an ER positive
(>90%) invasive lobular carcinoma (ILC) and treated by
arimidex for close to 8 months before her mastectomy.
The heterogeneity is readily spotted from the images and
also evidenced from the large standard deviations shown
on the histograms. Heterogeneity of the redox indices was
also evident from each of the core biopsy specimens of the







































































































DH; 3nd row: Fp redox ratio). Left column: averaging over whole
































































Figure 3 Typical mitochondrial redox images and the corresponding histograms of breast tumor tissue from a patient. Image matrix
256 × 64 (only partially displayed) and spatial resolution 100 μm.
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state reveals islands of viable cells existed in the necrotic
centers
Figure 4 & 5 show the images of Fp, NADH, and pyro-
2DG simultaneously acquired for two representative large
and necrotic tumors of MCF-7 and MDA-MB-231,
respectively. Also shown in these figures are the redox
ratio images and those of pyro-2DG/(Fp + NADH),
which are less sensitive to cell density variations by





















































































Figure 4 Typical mitochondrial redox state and Pyro-2DG uptake ima
section of a large MCF-7 tumor (>10 mm, Vol = 568 mm3). The Fp red
(Fp + NADH)) range between 0 and 1. The Fp, NADH, and Pyro-2DG image
For other notations see the legend of Figure 1.again observed significant intra-tumor heterogeneity of
the redox state and glucose uptake in both tumors, and
their corresponding histograms also exhibited a bimodal
or multi-modal distribution. Note that the large MCF-7
tumors had a core-rim pattern as the MDA-MB-231
tumors, which is not usually observed for smaller MCF-
7 tumors (≤10 mm).
Due to complete cell death, we can identify certain
central regions where there were no fluorescence signals













































ges and their corresponding histograms of a representative
ox ratio, NADH redox ratio, and normalized Pyro-2DG (Pyro-2DG/
s are in the unit of μM in reference to the corresponding standards.









































































































































Figure 5 Typical mitochondrial redox state and Pyro-2DG uptake images and their corresponding histograms of a representative






















Figure 6 Positive correlation between Pyro-2DG/(Fp + NADH) and
NADH/(Fp + NADH) for the MDA-MB-231 tumor in Figure 5.
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cated by strong NADH, Fp, and Pyro-2DG signals, partic-
ularly in the large MCF-7 tumor in Figure 4. Two islands
of viable cells in the tumor central region exhibit differen-
tial Pyro-2DG uptake as shown by the Pyro-2DG/(Fp +
NADH) image although their corresponding redox ratios
are similar.
In general, all four tumors had oxidized core and re-
duced peripheral regions mostly corresponding with the
lower and the higher pyro-2DG uptake, respectively, and
showed a positive correlation of the pyro-2DG signals
with NADH or NADH redox ratios in peripheral tissue
regions. Figure 6 is a plot of the distribution of the meta-
bolic indices, i.e., the normalized glucose uptake Pyro-
2DG/(Fp +NADH) versus the NADH redox ratio NADH/
(Fp +NADH) for the MDA-MB-231 tumor image section
displayed in Figure 5. A positive correlation is readily
identified between these two indices and the linear regres-
sion fit yields a correlation coefficient R2 = 0.68. For the
MCF-7 tumor image section in Figure 4, the positive cor-
relation between Pyro-2DG/(Fp +NADH) and NADH/
(Fp +NADH) is not as obvious and the linear regression
fit gives R2 = 0.24. Similar correlations between Pyro-2DG
or Pyro-2DG/(Fp +NADH) versus the redox indices
(NADH/(Fp +NADH) or NADH) were observed in gen-
eral for all four tumors. Despite the existing correlations,
the distributions of the glucose uptake level versus mito-
chondrial NADH or NADH redox ratio were relatively
scattered. On the correlation plots such as in Figure 6, for
each normalized pyro-2DG uptake level, there are a num-
ber of pixels with different values of redox indices, and
vice versa. Since the redox indices such as NADH and theNADH redox ratio are indicators of the mitochondrial
redox state, these observations demonstrate that each
pyro-2DG uptake level corresponds to a number of differ-
ent mitochondrial redox states, and each mitochondrial
redox state corresponds to a number of glucose uptake
levels. This result indicates that there is a whole variety of
cellular metabolic states existing in a breast tumor.Discussion
Tumor functional and metabolic heterogeneity has long
been recognized. Studies have shown that clinical tu-
mors exhibited more heterogeneous tissue oxygenation
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erogeneity of tissue oxygenation was larger than intratu-
mor heterogeneity; furthermore, the pO2 variations within
breast tumors measured by needle electrodes did not
correlate with the measuring site (tumor center versus pe-
riphery) (Vaupel et al. 2007; Vaupel et al. 1991). In addi-
tion to distinguishing between normal and (pre)malignant
tissues (Xu et al. 2013b; Xu et al. 2013a; Xu et al. 2011b),
imaging the intratumor heterogeneity of the mitochon-
drial redox state in tumors may provide useful informa-
tion for understanding tumor aggressiveness (Li 2012).
Our previous studies showed that more oxidized mito-
chondrial redox state in tumor tissue was positively asso-
ciated with tumor metastatic potential in the melanoma
and breast cancer xenograft models (Li et al. 2009a; Xu
et al. 2010). We also observed that the clinical cancerous
breast tissue was much more oxidized and more heteroge-
neous than the normal tissue (Xu et al. 2013a). The pres-
ent study shows with great details of the metabolic
heterogeneity in breast tumor xenografts and breast
tumor specimens, which may be further investigated for
developing high resolution biomarkers for clinical
applications.
The present study is the first to reveal the 3D distribu-
tion of the mitochondrial redox state and Fp and NADH
distribution in entire breast tumor xenografts. The three
tumor lines we used in the study have the following as-
cending aggressiveness or invasive/metastatic potential,Figure 7 Typical H&E staining of an area within the necrotic center o
cells (bar = 200 μm).MCF-7 <MDA-MB-468 <MDA-MB-231 (Freund et al.
2003). Both MDA-MB-468 and MDA-MB-231 cells are
triple-negative (negative for estrogen receptor, Her2/
neu, and progesterone receptor) (Köster et al. 2009;
Bartholomeusz et al. 2010; Anders & Carey 2008) and
belong to aggressive tumors. From the redox images, we
have observed significantly higher degree of heterogeneity
in the more metastatic MDA-MB-231 and MDA-MB-468
tumors and less heterogeneity in the less metastatic
MCF-7 tumors (≤10 mm). More quantitative analysis of
the redox indices and their correlation with the aggres-
siveness of these three xenograft models is in progress.
We also observed that MCF-7 tumors larger than 10 mm
in diameter became more heterogeneous with distinct
core-rim imaging pattern and the oxidized regions having
very high Fp redox ratio (Figure 4). This result suggested
that the large MCF-7 tumors may have acquired more ag-
gressive features, consistent with the clinical observations
that larger tumors tend to be more aggressive/metastatic.
We also investigated the glucose uptake by simulta-
neously imaging the fluorescence tracer pyro-2DG and
the mitochondrial redox state in four large tumors. The
results indicated that there were a large variety of cellular
metabolic states existing under the complex tumor micro-
environment. Although there are intertumor variations,
the common patterns are that these tumors all exhibited
more oxidized states in tumor central regions and more
reduced states in tumor peripherals, and the normalizedf a large MCF-7 tumor (>10 mm) showing islands of viable
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correlated with NADH/(Fp + NADH) in the tumor
periphery. Early studies using bioluminescent enzymatic
assay demonstrated the heterogeneous spatial distribution
of glucose, lactate, and ATP in human breast cancer xeno-
grafts in rats (Kallinowski et al. 1988). Heterogeneous
uptake of glucose by cancer cells in tumor xenografts was
also quantitatively evaluated by radioluminography show-
ing the selective uptake of deoxyglucose for viable cells
over necrotic regions (Dearling et al. 2004). Such selectiv-
ity was also seen in the present study where tumor periph-
eral areas have apparently higher Pyro-2DG uptake,
corresponding to higher NADH and the NADH redox
ratio. This can be explained by the presumably higher
perfusion and nutrient delivery and more NADH being
metabolically generated in the tumor peripheral areas than
in the central regions.
We also observed pronounced Pyro-2DG uptake in the
areas inside the necrotic center along with significant
NADH and Fp signals. High glucose uptake and NADH
concentration inside the necrotic center indicate that
these cells had high metabolic activities. It is likely that
these cells were in State 3 where cells had sufficient nutri-
ent resulting in rapid oxidative metabolism (high NADH,
Fp and the Fp redox ratio) rather than in State 2 where
cells were nutrient-starved (low NADH, high Fp and the
Fp redox ratio) (Chance & Williams 1955; Chance &
Baltscheffsky 1958; Chance & Schoener 1966). This also
provides a possible answer to our previous question
regarding whether the cancer cells in the oxidized regions
were in State 2 (starvation) or State 3 (sufficient sub-
strates) (Li et al. 2009a; Xu et al. 2010). According to the
present study, it seems that the answer is some were in
State 2 and some in State 3.
The metabolic status of the cells in the necrotic center
has not received noticeable attentions. The cells in the
necrotic area are often considered dead due to limited
blood perfusion that usually happens for aggressive tu-
mors in mouse xenografts (Li et al. 2009a; Bradley et al.
2007; Pedley et al. 2001; Ranney et al. 2005). However,
“hot” spots with high uptake of radiolabeled glucose
were reported to exist in the necrotic areas of tumors in
the literature (Dearling et al. 2004). Our previous studies
on metastatic melanoma mouse xenografts also found that
there was a sizable portion of cells inside the necrotic cen-
ters with intact nuclei shown by both the H&E staining
and DAPI staining as well as TUNEL negativity, all of
which indicated they were viable (Xu et al. 2010; Xu et al.
2009b). The H&E staining of breast tumor xenografts also
showed islands of cells with intact nuclei in the necrotic/
oxidized regions (Figure 7). It is the redox indices in the
oxidized tumor core that readily distinguish between the
aggressive and indolent xenografts, better than the whole
section average (Li et al. 2009a; Xu et al. 2010). Theseapparently viable cells in the oxidized cores may provide
important clues to understanding tumor aggressiveness or
metastatic potential.
Conclusions
We reported the preliminary results from 3D high resolu-
tion mapping of the mitochondrial redox state of three
breast cancer lines xenografted in mice, i.e., MCF-7,
MDA-MB-468, and MDA-MB-231 with increasing ranks
of metastatic potential. We identified significant intertu-
mor and intratumor heterogeneity of the redox state
among all xenografts and for the first time revealed the
mitochondrial redox state spatial distribution in an entire
tumor. Additionally, we showed that high degree of het-
erogeneity existed in the clinical biopsy samples from the
breast cancer patients. We also reported the preliminary
results of simultaneous imaging of the mitochondrial
redox state and glucose uptake in larger breast cancer
xenografts with apparent necrotic centers. We found that
the glucose uptake was also heterogeneous (usually higher
in tumor periphery) and positively correlates with NADH
and the NADH redox ratio in general but not in all
regions, and that islands of viable cells existed in tumor
necrotic/oxidized centers exhibiting both high glucose
uptake and NADH. These results indicated that a variety
of metabolic states exist in a breast tumor and the meta-
bolic heterogeneity warrants further investigation for
developing potential metabolic biomarkers for clinical
applications.
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